|
Re: BETonMACE details
|
6
|
Resverlogix Corp.
|
May 16, 2018 08:11PM
|
|
Re: is anyone thinking or expecting any movement in the sp or
|
6
|
Resverlogix Corp.
|
Jan 05, 2016 01:00PM
|
|
Re: New research report 5/11/16 by Marcel Wijma, Van Leeuwenhoeck Institute
|
6
|
Resverlogix Corp.
|
May 12, 2016 11:17AM
|
|
Re: Zenith Epigenetics Announces Dosing of First Patient in Triple Negative Breast Cancer Trial with Pfizer
|
6
|
Zenith Epigenetics
|
Oct 18, 2019 12:56PM
|
|
Re: BETonMACE details
|
6
|
Resverlogix Corp.
|
May 16, 2018 08:32PM
|
|
Re: Resverlogix October 2018 events
|
6
|
Resverlogix Corp.
|
Oct 18, 2018 08:46AM
|
|
Re: Hepalink Anniversary - Apr 27
|
6
|
Resverlogix Corp.
|
Apr 26, 2016 11:09AM
|
|
New article on BET Inhibitors in Cardiovascular Disease
|
6
|
Resverlogix Corp.
|
Jan 30, 2019 01:22PM
|
|
Re: BIO Investor Forum, Oct 22-23
|
6
|
Zenith Epigenetics
|
Oct 18, 2019 01:01PM
|
|
The new competitors: SGLT2 inhibitors and GLP-1 Receptor Agonists
|
6
|
Resverlogix Corp.
|
Jun 13, 2016 11:43PM
|
|
Re: RRR %
|
6
|
Resverlogix Corp.
|
Jul 01, 2019 08:47AM
|
|
Slide Deck from Cowen Health Care Conference 3/8/17
|
6
|
Resverlogix Corp.
|
Mar 08, 2017 03:41PM
|
|
Re: Veterinary Applications?
|
6
|
Zenith Epigenetics
|
Aug 06, 2017 09:21AM
|
|
The glucose effect?
|
6
|
Resverlogix Corp.
|
Feb 21, 2019 01:34PM
|
|
Re: BETonMACE Enrollment
|
6
|
Resverlogix Corp.
|
Aug 30, 2017 06:18PM
|
|
Re: ESC Wrap Up for Sunday Sept 1....
|
6
|
Resverlogix Corp.
|
Sep 02, 2019 12:01PM
|
|
Re: DSMB 7th review??
|
6
|
Resverlogix Corp.
|
Jul 18, 2018 11:41PM
|
|
The 3 inflection points: SSRA, Top-Line, Full Data
|
6
|
Resverlogix Corp.
|
Sep 09, 2018 06:40PM
|
|
FYI, Zenith update on Thursday 6/18
|
6
|
Resverlogix Corp.
|
Jun 16, 2020 07:20AM
|
|
Re: Resverlogix presenting at Vascular Discovery 2019 next week
|
6
|
Resverlogix Corp.
|
May 15, 2019 07:54PM
|
